Walgreens Infusion Services Named a Limited Network Home Infusion Provider for New Continuous Intravenous Infusion Therapy BLINCYTO™ (blinatumomab) Immunotherapy
DEERFIELD, Ill., January 15, 2015 – Walgreens today announced that, effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for BLINCYTO™ (blinatumomab), a therapy for the treatment of patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BLINCYTO™ can now be obtained through and administered […]